ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,240Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 2056

$610K Total Retail Price of All Prescriptions

Rank: 30 out of 2056

398 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

12% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 426 384 1 1
OMEPRAZOLE 421 379 2 4
SIMVASTATIN 391 368 3 2
CITALOPRAM HBR 323 254 4 15
LEVOTHYROXINE SODIUM 319 293 5 3
AMLODIPINE BESYLATE 292 276 6 6
HYDROCODONE-ACETAMINOPHEN 267 177 S3 7 5
HYDROCHLOROTHIAZIDE 264 248 8 7
LOSARTAN POTASSIUM 225 219 9 13
PRAVASTATIN SODIUM 203 197 10 20
ZOLPIDEM TARTRATE 203 163 10 23
METOPROLOL SUCCINATE 179 161 12 19
WARFARIN SODIUM 171 165 13 12
ATORVASTATIN CALCIUM 165 137 14 17
FUROSEMIDE 154 137 15 9
ATENOLOL 153 140 16 10
METOPROLOL TARTRATE 152 136 17 11
DIGOXIN 137 136 18 53
GABAPENTIN 136 99 19 14
TAMSULOSIN HCL 117 108 20 28
METFORMIN HCL 117 110 20 8
FLUTICASONE PROPIONATE 108 85 22 31
PAROXETINE HCL 105 66 23 58
ALLOPURINOL 99 85 24 32
LOVASTATIN 98 93 25 16
OXYCODONE HCL 90 25 S2 26 24
FINASTERIDE 89 85 27 90
ALENDRONATE SODIUM 86 79 28 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 72 29 116
CARVEDILOL 84 78 29 35
SERTRALINE HCL 83 61 31 25
CRESTOR 80 63 32 30
PANTOPRAZOLE SODIUM 77 63 33 55
TRAZODONE HCL 76 70 34 21
JANUVIA 74 55 35 121
DIOVAN 72 67 36 68
POTASSIUM CHLORIDE 68 52 37 18
MIRTAZAPINE 65 56 38 45
DICLOFENAC SODIUM 64 47 39 95
PROAIR HFA 64 49 39 29
QUETIAPINE FUMARATE 63 56 41 61
BUPROPION HCL SR 63 45 41 104
POLYETHYLENE GLYCOL 3350 62 55 43 50
GLYBURIDE 61 61 R 44 66
METHADONE HCL 59 14 S2 45 49
SPIRONOLACTONE 57 41 46 63
DONEPEZIL HCL 52 52 47 37
ROPINIROLE HCL 50 35 48 98
FLUOXETINE HCL 50 41 48 33
SPIRIVA 50 42 48 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.